Nevro

$177.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.47 (-0.26%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Nevro and other stocks, options, and ETFs commission-free!

About NVRO

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA. The listed name for NVRO is NEVRO CORP.

CEO

D. Keith Grossman

Employees

853

Headquarters

Redwood City, California

Founded

2006

Market Cap

6.10B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

722.09K

High Today

$180.45

Low Today

$177.25

Open Price

$177.51

Volume

584.01K

52 Week High

$188.14

52 Week Low

$65.05

Collections

Analyst Ratings

79%

of 14 ratings

Buy

79%

Hold

21%

Sell

NVRO Earnings

-$1.62

-$1.08

-$0.54

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 24, After Hours